2026

Lymphocytic Choriomeningitis Virus Bearing GPC Mutations for Enhanced Tumor Tropism and Strong Anti-Tumor Activity

Friedrich-Becker, S.-K. et al., Viruses

Read more here

2026

Mutations at Positions 181 and 185 Wthin the LCMV GP Protein Increase Tumor Cell Infectivity, Limit Induction of Type I Interferon, and Accelerate T Cell Activation

Bergerhausen, M. et al., Viruses

Read more here

2025

Optimized arenaviruses with tumor-tropic mutations promote safe anti-tumor efficacy via sustainable immune modulatory properties

Lang, P.A. et al., Cell Reports Medicine

Read more here

2023

The role of glycosylation patterns of viral glycoproteins and cell entry receptors in arenavirus infection.

Gorzkiewicz, Michal et al., Biomedicine & Pharmacotherapy

Read more here

2019

Viral infection overcomes ineffectiveness of anti-tumoral CD8+ T cell mediated cytotoxicity

Zhou, F. et al., bioRxiv

Read more here

2017

Spatiotemporally restricted arenavirus replication induces immune surveillance and type I interferon-dependent tumour regression.

Kalkavan, H. et al., Nature Communications

Read more here

2017

IRF9 Prevents CD8+ T Cell Exhaustion in an Extrinsic Manner during Acute Lymphocytic Choriomeningitis Virus Infection

Huber, M. et al., Journal of Virology

Read more here

2014

Type I Interferon Protects Antiviral CD8+ T Cells from NK Cell Cytotoxicity

Xu, H. C. et al., Immunity

Read more here